Catholic MASTER Cell Therapy

N/A

Report date: 2024/11/21 20:00:04

Base Information

Drug NameCatholic MASTER Cell Therapy

Drug Alias NameBone Marrow Derived Mesenchymal Stem Cell

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, Knee

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThe Catholic University Of Korea, Seoul St. Mary’S Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Catholic University Of Korea, Seoul St. Mary’S Hospital

Active IndicationsN/A

Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A